Recovery of Bone Mineral Density Following Discontinuation of Tenofovir-Based HIV Pre-Exposure Prophylaxis

BACKGROUND: Oral tenofovir disoproxil fumarate (TDF) for HIV prevention and treatment is associated with decreases in bone mineral density (BMD). Previous reports suggest that these changes may be reversible after discontinuation of TDF. SETTING: A metabolic substudy of 498 participants in a randomi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Acquir Immune Defic Syndr
Autors principals: Glidden, David V., Mulligan, Kathleen, McMahan, Vanessa, Anderson, Peter L, Guanira, Juan, Chariyalertsak, Suwat, Buchbinder, Susan P., Bekker, Linda Gail, Schechter, Mauro, Grinsztejn, Beatriz, Grant, Robert M.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5597476/
https://ncbi.nlm.nih.gov/pubmed/28639995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars